By Helen Durkin
Type 2 diabetes has taken a hold on our country — financially and in terms of human cost.
Simply having diabetes puts a person at significant risk for other serious, debilitating health issues. It complicates people’s lives, makes their health
By Ben Adams
Japanese Big Pharma Takeda and U.S. partner Zinfandel Pharmaceuticals have decided to give up and stop testing a 20-year-old diabetes medicine that they hoped could work as a new Alzheimer’s therapy.
The details from the brief update: The so
By Kenneth E. Thorpe
The Trump administration is pressing forward with Nafta renegotiations. America's trade representatives tried to resolve their disagreements with their Mexican and Canadian counterparts in informal meetings throughout December. A sixth round of talks will
Alzheimer’s care and caregiver costs demand greater efforts towards early detection, innovation
January 25, 2018 (Washington, D.C.) Recent research data developed by IHS Markit and the Partnership to Fight Chronic Disease (PFCD) projects the cumulative total cost of Alzheimer’s
"The Partnership to Fight Chronic Disease (PFCD) congratulates Alex Azar on his confirmation as Secretary of Health and Human Services, and affirms our commitment to working with him to ensure our health care system works effectively to promote health and well-being in America. Secretary Azar
As obesity continues to rise in the United States, the epidemic will have a devastating effect on the future health of Americans and their healthcare system.
By Shawn Radcliffe
More than half of current children and teens in the United States could be obese
By David H. Freedman
When it comes to some of the biggest diseases America faces in the future, our drug system is set up to fail. What needs to happen?
If there’s a dream of what a new drug is supposed to do, it might look something like Kalydeco. In
Alzheimer’s health care and caregiver cost impact far greater than meets the eye
November 20, 2017 (Washington, D.C.) Recent research data developed by IHS Markit on behalf of the Partnership to Fight Chronic Disease (PFCD) projects the cumulative total cost of Alzheimer’s
People with type 2 diabetes more than twice as likely to develop cardiovascular disease, lower life expectancy
November 9, 2017 (Washington, D.C.) The Partnership to Fight Chronic Disease (PFCD) today hosted an important health observance briefing to raise awareness of the co-occurrence
By Kenneth Thorpe, Kathy Ko Chin, Yanira Cruz, Marjorie A. Innocent, and Lillian Singh
Health Affairs Blog
“It is natural to ask whether rising gaps in income might be associated with widening gaps in health and longevity between rich and poor Americans,